FH535 inhibited migration and growth of breast cancer cells.

FH535 inhibited migration and growth of breast cancer cells.
复制标题

DOI:
10.1371/journal.pone.0044418
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Shriver CD
Shriver CD
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Iida J;Dorchak J;Lehman JR;Clancy R;Luo C;Chen Y;Somiari S;Ellsworth RE;Hu H;Mural RJ;Shriver CD

文献摘要

参考文献

被引文献

相似文献

有大量证据表明,WNT信号通路在包括乳腺癌在内的各种癌细胞类型中被激活。先前的研究报道,FH 535,一种WNT信号通路的小分子抑制剂,降低了癌细胞的生长,但不是正常的成纤维细胞,这表明该通路在肿瘤进展和转移中起作用。在这项研究中,我们测试了FH 535作为乳腺癌细胞恶性表型的潜在抑制剂,包括迁移,侵袭和生长。FH 535在体外显著抑制三阴性(TN)乳腺癌细胞系(MDA-MB 231和HCC 38)的生长、迁移和侵袭。我们证明,当在三维(3D)I型胶原凝胶中培养时,FH 535是TN乳腺癌细胞系(HCC 38和MDA-MB-231)的有效生长抑制剂,但对其他非TN乳腺癌细胞系(MCF-7、T47 D或SK-Br 3)不是。Western印迹分析表明,用FH 535处理MDA-MB-231细胞显著抑制NEDD 9的表达,但不激活FAK、Src或下游靶点如p38和Erk 1/2。我们证明,在MDA-MB-231细胞中,NEDD 9与CSPG 4特异性相关,但与β1整合素或CD 44无关。乳腺癌组织中基因表达谱的分析表明,CSPG 4表达在基底型乳腺癌中高于任何其他亚型,其中许多是TN。这些结果表明,不仅涉及经典的WNT信号通路的迁移和入侵的机制,但也治疗谁开发TN乳腺癌患者的新策略。
There is substantial evidence indicating that the WNT signaling pathway is activated in various cancer cell types including breast cancer. Previous studies reported that FH535, a small molecule inhibitor of the WNT signaling pathway, decreased growth of cancer cells but not normal fibroblasts, suggesting this pathway plays a role in tumor progression and metastasis. In this study, we tested FH535 as a potential inhibitor for malignant phenotypes of breast cancer cells including migration, invasion, and growth. FH535 significantly inhibited growth, migration, and invasion of triple negative (TN) breast cancer cell lines (MDA-MB231 and HCC38) in vitro. We demonstrate that FH535 was a potent growth inhibitor for TN breast cancer cell lines (HCC38 and MDA-MB-231) but not for other, non-TN breast cancer cell lines (MCF-7, T47D or SK-Br3) when cultured in three dimensional (3D) type I collagen gels. Western blotting analyses suggest that treatment of MDA-MB-231 cells with FH535 markedly inhibited the expression of NEDD9 but not activations of FAK, Src, or downstream targets such as p38 and Erk1/2. We demonstrated that NEDD9 was specifically associated with CSPG4 but not with β1 integrin or CD44 in MDA-MB-231 cells. Analyses of gene expression profiles in breast cancer tissues suggest that CSPG4 expression is higher in Basal-type breast cancers, many of which are TN, than any other subtypes. These results suggest not only a mechanism for migration and invasion involving the canonical WNT-signaling pathways but also novel strategies for treating patients who develop TN breast cancer.
DOI: 10.1038/sj.emboj.7601606
发表时间: 2007-03-21
期刊: EMBO JOURNAL
影响因子: 11.4
作者:
Bravo-Cordero, Jose J.;Marrero-Diaz, Raquel;Montoya, Maria C.
通讯作者: Montoya, Maria C.
DOI: 10.1074/jbc.m010053200
发表时间: 2001-06-01
影响因子: 4.8
作者:
Iida, J;Pei, D;McCarthy, JB
通讯作者: McCarthy, JB
Wnt途径基因的遗传变化是乳房化生癌中的常见事件。
DOI: 10.1158/1078-0432.ccr-07-4379
发表时间: 2008-07-01
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者:
Hayes MJ;Thomas D;Emmons A;Giordano TJ;Kleer CG
通讯作者: Kleer CG
DOI: 10.1038/modpathol.2010.205
发表时间: 2011-02-01
期刊: MODERN PATHOLOGY
影响因子: 7.5
作者:
Geyer, Felipe C.;Lacroix-Triki, Magali;Reis-Filho, Jorge S.
通讯作者: Reis-Filho, Jorge S.
DOI: 10.1091/mbc.7.3.383
发表时间: 1996-03-01
影响因子: 3.3
作者:
Knutson, JR;Iida, J;McCarthy, JB
通讯作者: McCarthy, JB